These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15716694)

  • 1. Stromelysin-1 (MMP-3) gene 5A/6A promoter polymorphism is associated with blood pressure in a community population.
    Beilby JP; Chapman CM; Palmer LJ; McQuillan BM; Thompson PL; Hung J
    J Hypertens; 2005 Mar; 23(3):537-42. PubMed ID: 15716694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects.
    Gnasso A; Motti C; Irace C; Carallo C; Liberatoscioli L; Bernardini S; Massoud R; Mattioli PL; Federici G; Cortese C
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1600-5. PubMed ID: 10845878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction.
    Liu PY; Chen JH; Li YH; Wu HL; Shi GY
    Thromb Haemost; 2003 Jul; 90(1):132-9. PubMed ID: 12876636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction.
    Terashima M; Akita H; Kanazawa K; Inoue N; Yamada S; Ito K; Matsuda Y; Takai E; Iwai C; Kurogane H; Yoshida Y; Yokoyama M
    Circulation; 1999 Jun; 99(21):2717-9. PubMed ID: 10351963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Matrix metalloproteinase-3 genotype distribution and its relation with blood pressure profiles in Guangzhou rural population].
    Shao Y; Deng M; Lian Z; Shi M; Jiang X
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):586-9. PubMed ID: 23644126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.
    Sherva R; Ford CE; Eckfeldt JH; Davis BR; Boerwinkle E; Arnett DK
    Stroke; 2011 Feb; 42(2):330-5. PubMed ID: 21183746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromelysin gene promoter polymorphism and common carotid geometry in diabetic subjects.
    Irace C; Cortese C; Migale M; Liberatoscioli L; Mannucci L; Federici G; Gnasso A
    Int Angiol; 2008 Oct; 27(5):413-8. PubMed ID: 18974705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis.
    Djurić T; Zivković M; Radak D; Jekić D; Radak S; Stojković L; Raicević R; Stanković A; Alavantić D
    Clin Biochem; 2008 Nov; 41(16-17):1326-9. PubMed ID: 18801353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial NOS G894 T and MMP-3 5A/6A gene polymorphisms and hypertension in Serbian population.
    Djurić T; Zivković M; Stanković A; Mecanin S; Alavantić D
    J Clin Lab Anal; 2005; 19(6):241-6. PubMed ID: 16302209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygosity of stromelysin-1 (rs3025058) promoter polymorphism is associated with gastric cancer.
    Krishnaveni D; Bhayal AC; Shravan KP; Jyothy A; Pratibha N; Venkateshwari A
    Indian J Cancer; 2015; 52(2):251-4. PubMed ID: 26853425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.
    Chaudhary AK; Singh M; Bharti AC; Singh M; Shukla S; Singh AK; Mehrotra R
    BMC Cancer; 2010 Jul; 10():369. PubMed ID: 20630073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMP-3 (5A/6A) polymorphism does not influence human smooth muscle cell invasion.
    Maqbool A; Keswani A; Galloway S; O'Regan DJ; Ball SG; Turner NA; Porter KE
    J Surg Res; 2012 Jun; 175(2):343-9. PubMed ID: 21601886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic contribution to carotid vascular disease in patients with systemic lupus erythematosus.
    Marasini B; Massarotti M; De Monti M; Erario M; Ghilardi G; Biondi ML
    J Clin Immunol; 2008 Mar; 28(2):131-3. PubMed ID: 17975717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5A/6A polymorphism of the stromelysin-1 gene and angiographic restenosis after coronary artery stenting.
    Chiou KR; Chung SL; Charng MJ
    J Chin Med Assoc; 2005 Nov; 68(11):506-12. PubMed ID: 16323393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression.
    Medley TL; Kingwell BA; Gatzka CD; Pillay P; Cole TJ
    Circ Res; 2003 Jun; 92(11):1254-61. PubMed ID: 12750310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina.
    Kim JS; Park HY; Kwon JH; Im EK; Choi DH; Jang YS; Cho SY
    Yonsei Med J; 2002 Aug; 43(4):473-81. PubMed ID: 12205736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of 5A/6A polymorphism of matrix metalloproteinase-3 on recurrent atherosclerotic ischemic stroke in Chinese.
    Huang XY; Han LY; Huang XD; Guan CH; Mao XL; Ye ZS
    Int J Neurosci; 2016 Oct; 126(10):936-41. PubMed ID: 26314579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
    Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Köppel H; Leithner A; Wascher TC; Paulweber B; Samonigg H
    Clin Cancer Res; 2004 May; 10(10):3518-20. PubMed ID: 15161710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy.
    Gantala SR; Kondapalli MS; Kummari R; Padala C; Tupurani MA; Kupsal K; Galimudi RK; Gundapaneni KK; Puranam K; Shyamala N; Guditi S; Rapur R; Hanumanth SR
    Gene; 2018 Oct; 673():22-31. PubMed ID: 29883760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis.
    Rauramaa R; Väisänen SB; Luong LA; Schmidt-Trücksäss A; Penttilä IM; Bouchard C; Töyry J; Humphries SE
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2657-62. PubMed ID: 11116068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.